H-InvDB x AHG DB
Similarity Search Tool
H-InvDB_8.3 released on March 26, 2013.
Search by for Advanced Search
Home Quick guide Navi BLAST Site map Download Contact us Help


H-Inv ID Program Identity E-Value Organism
HIT000244018 FASTY 34t22b3
NCBI-BLASTX 2.2.9
=75%
=50%
=25%
all
0
0-10
all
Homo sapiens
Vertebrate ( non Homo sapiens )
Eukaryote ( non Vertebrate )
Bacteria & Virus
Others
SHOW DATA
FASTY 34t22b3
 
A.A. Length
Identity(%) Score E-Value Species Description
P06312 aa overlap(8-370:1-121)
coverage(51.05% : 100.00%) 121 Original alignment 100.0 888.4 2.3e-41 Hom Ig kappa chain V-IV region precursor (Fragment).
P06313 aa overlap(8-370:1-121)
coverage(51.05% : 90.98%) 133 Original alignment 97.5 865.8 4.1e-40 Hom Ig kappa chain V-IV region JI precursor.
P01625 aa overlap(68-385:1-106)
coverage(44.73% : 92.98%) 114 Original alignment 95.3 742.7 3e-33 Hom Ig kappa chain V-IV region Len.
P06314 aa overlap(8-385:1-126)
coverage(53.16% : 94.03%) 134 Original alignment 94.4 873.4 1.5e-40 Hom Ig kappa chain V-IV region B17 precursor.
P83593 aa overlap(68-385:1-106)
coverage(44.73% : 97.25%) 109 Original alignment 88.7 690.3 2.5e-30 Hom Ig kappa chain V-IV region STH (Fragment).
A0N262 aa overlap(68-364:2-100)
coverage(41.77% : 86.09%) 115 Original alignment 84.8 633.9 3.4e-27 Verteb Vk protein (Fragment).
A2N494 aa overlap(68-376:1-103)
coverage(43.46% : 90.35%) 114 Original alignment 84.5 664.7 6.5e-29 Verteb Aberrantly recombined kappa chain Vk8/J1 region (Fragment).
A0N6R3 aa overlap(137-376:1-80)
coverage(33.76% : 90.91%) 88 Original alignment 83.8 489.6 3.7e-19 Verteb Rheumatoid factor RF4-2F (Fragment).
A2NW98 aa overlap(8-385:1-126)
coverage(53.16% : 94.03%) 134 Original alignment 81.7 768.0 1.2e-34 Hom Rheumatoid factor light chain variable region precursor (Fragment).
Q52L64 aa overlap(17-376:4-123)
coverage(50.63% : 50.00%) 240 Original alignment 78.3 716.0 9.1e-32 Verteb ENSMUSG00000076577 protein.
Q9NP29 aa overlap(8-383:1-125)
coverage(52.88% : 96.15%) 130 Original alignment 77.6 689.1 2.9e-30 Hom Microfibrillar protein 2 (Fragment).
A2NC20 aa overlap(17-376:4-123)
coverage(50.63% : 90.23%) 133 Original alignment 76.7 714.2 1.1e-31 Verteb CC49 Fab precursor (Fragment).
Q6KB05 aa overlap(56-376:133-239)
coverage(45.15% : 41.96%) 255 Original alignment 75.7 589.3 1e-24 Verteb ScFv B8E5 protein (Fragment).
Q9UL83 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 70.9 499.2 1.1e-19 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
Q9UL85 aa overlap(68-373:1-96)
coverage(43.04% : 88.07%) 109 Original alignment 70.6 511.3 2.3e-20 Hom Myosin-reactive immunoglobulin kappa chain variable region (Fragment).
A2NXP9 aa overlap(68-370:1-96)
coverage(42.62% : 87.27%) 110 Original alignment 70.3 536.5 9.1e-22 Hom K light chain variable region (Fragment).
A8MYQ2 aa overlap(68-346:1-92)
coverage(39.24% : 100.00%) 92 Original alignment 69.9 467.3 6.5e-18 Hom Uncharacterized protein ENSP00000375538 (Fragment).
P01668 aa overlap(68-355:1-94)
coverage(40.51% : 85.45%) 110 Original alignment 69.8 499.1 1.1e-19 Verteb Ig kappa chain V-III region PC 7210.
Q96SA9 aa overlap(68-367:1-94)
coverage(42.19% : 87.85%) 107 Original alignment 69.0 498.2 1.2e-19 Hom Anti-streptococcal/anti-myosin immunoglobulin kappa light chain variable region (Fragment).
P01605 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 68.9 524.5 4.2e-21 Hom Ig kappa chain V-I region Lay.
P01665 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 68.9 515.5 1.3e-20 Verteb Ig kappa chain V-III region PC 7043.
P01667 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 68.9 515.5 1.3e-20 Verteb Ig kappa chain V-III region PC 6308.
P01666 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 68.9 515.5 1.3e-20 Verteb Ig kappa chain V-III region PC 7183.
Q9UL70 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 68.9 506.9 4e-20 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
Q9UL81 aa overlap(68-364:1-93)
coverage(41.77% : 86.92%) 107 Original alignment 68.7 493.8 2.2e-19 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
A2NYV3 aa overlap(74-385:1-98)
coverage(43.88% : 93.33%) 105 Original alignment 68.3 508.2 3.4e-20 Hom Light chain Fab (Fragment).
Q5F2I7 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 68.0 515.5 1.3e-20 Verteb Kappa light chain variable region (Fragment).
Q9UL78 aa overlap(68-376:1-98)
coverage(43.46% : 89.91%) 109 Original alignment 68.0 521.1 6.5e-21 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
A0N7D1 aa overlap(68-376:1-101)
coverage(43.46% : 87.83%) 115 Original alignment 68.0 515.3 1.4e-20 Verteb SD6 Fab kappa light chain variable region (Fragment).
Q9UL77 aa overlap(68-367:1-94)
coverage(42.19% : 87.04%) 108 Original alignment 68.0 491.5 2.9e-19 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
Q9UL79 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 67.9 521.2 6.4e-21 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
Q9JL74 aa overlap(98-376:3-89)
coverage(39.24% : 87.88%) 99 Original alignment 67.7 461.4 1.4e-17 Verteb Anti-myosin immunoglobulin light chain variable region (Fragment).
Q65ZN3 aa overlap(68-373:1-100)
coverage(43.04% : 90.09%) 111 Original alignment 67.6 507.8 3.6e-20 Verteb Rheumatoid factor RF10-2 (Fragment).
A2N1N1 aa overlap(26-376:6-122)
coverage(49.37% : 87.31%) 134 Original alignment 67.5 602.2 2e-25 Verteb B cell antigen receptor precursor.
P06309 aa overlap(56-385:1-109)
coverage(46.41% : 93.16%) 117 Original alignment 67.3 519.6 7.9e-21 Hom Ig kappa chain V-II region GM607 precursor (Fragment).
P01621 aa overlap(65-358:4-96)
coverage(41.35% : 93.00%) 100 Original alignment 67.3 501.9 7.6e-20 Hom Ig kappa chain V-III region NG9 precursor (Fragment).
P01632 aa overlap(68-376:1-103)
coverage(43.46% : 90.35%) 114 Original alignment 67.3 487.9 4.6e-19 Verteb Ig kappa chain V-I region S107A.
P01624 aa overlap(68-385:1-101)
coverage(44.73% : 92.66%) 109 Original alignment 67.0 515.6 1.3e-20 Hom Ig kappa chain V-III region POM.
P01673 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 510.0 2.7e-20 Verteb Ig kappa chain V-III region PC 2485/PC 4039.
P01669 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 506.7 4.1e-20 Verteb Ig kappa chain V-III region PC 7769.
P01672 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 505.7 4.7e-20 Verteb Ig kappa chain V-III region PC 7940.
P01670 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 503.5 6.3e-20 Verteb Ig kappa chain V-III region PC 6684.
P01671 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 502.4 7.2e-20 Verteb Ig kappa chain V-III region PC 7175.
P01660 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 502.4 7.2e-20 Verteb Ig kappa chain V-III region PC 3741/TEPC 111.
P01664 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 499.1 1.1e-19 Verteb Ig kappa chain V-III region CBPC 101.
Q920E9 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 67.0 503.5 6.3e-20 Verteb Pterin-mimicking anti-idiotope kappa chain variable region (Fragment).
A2JA16 aa overlap(68-376:1-97)
coverage(43.46% : 90.65%) 107 Original alignment 67.0 497.1 1.4e-19 Hom Anti-mucin1 light chain variable region (Fragment).
A2IPI0 aa overlap(68-385:3-102)
coverage(44.73% : 88.50%) 113 Original alignment 67.0 511.0 2.4e-20 Hom HRV Fab N6-VL (Fragment).
P01696 aa overlap(71-352:1-90)
coverage(39.66% : 81.82%) 110 Original alignment 67.0 445.3 1.1e-16 Verteb Ig kappa chain V region K29-213.
P04207 aa overlap(8-373:1-116)
coverage(51.48% : 89.92%) 129 Original alignment 66.4 576.1 5.7e-24 Hom Ig kappa chain V-III region CLL precursor (Rheumatoid factor).
A2KBB9 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 66.4 521.7 6.1e-21 Hom Anti-(ED-B) scFV (Fragment).
A2KBC0 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 66.4 521.7 6.1e-21 Hom Anti-(ED-B) scFV (Fragment).
A2KBC5 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 66.4 518.4 9.3e-21 Hom Anti-HCS scFv (Fragment).
A2NN81 aa overlap(56-376:154-259)
coverage(45.15% : 39.41%) 269 Original alignment 66.4 500.0 9.8e-20 Verteb B9-scFv.
A0N6Q6 aa overlap(95-370:1-90)
coverage(38.82% : 86.54%) 104 Original alignment 66.3 459.9 1.7e-17 Verteb Rheumatoid factor RF3-5A (Fragment).
A2NB45 aa overlap(68-385:1-105)
coverage(44.73% : 92.92%) 113 Original alignment 66.0 503.3 6.4e-20 Hom Cold agglutinin FS-1 L-chain (Fragment).
P01622 aa overlap(68-385:1-101)
coverage(44.73% : 92.66%) 109 Original alignment 66.0 522.2 5.6e-21 Hom Ig kappa chain V-III region Ti.
P01620 aa overlap(68-385:1-101)
coverage(44.73% : 92.66%) 109 Original alignment 66.0 522.2 5.6e-21 Hom Ig kappa chain V-III region SIE.
P01662 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 66.0 491.4 3e-19 Verteb Ig kappa chain V-III region ABPC 22/PC 9245.
P01663 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 66.0 490.3 3.4e-19 Verteb Ig kappa chain V-III region PC 4050.
A2IPI3 aa overlap(68-385:3-103)
coverage(44.73% : 88.60%) 114 Original alignment 66.0 527.4 2.9e-21 Hom HRV Fab N28-VL (Fragment).
A2IPI5 aa overlap(68-385:3-102)
coverage(44.73% : 88.50%) 113 Original alignment 66.0 508.8 3.1e-20 Hom HRV Fab 026-VL (Fragment).
A2IPI2 aa overlap(68-367:3-97)
coverage(42.19% : 82.61%) 115 Original alignment 66.0 499.9 9.9e-20 Hom HRV Fab N27-VL (Fragment).
A0N7J3 aa overlap(68-376:1-102)
coverage(43.46% : 46.58%) 219 Original alignment 66.0 484.9 6.8e-19 Verteb Mc5 VLCL (Fragment).
Q5F2I0 aa overlap(68-373:1-101)
coverage(43.04% : 87.83%) 115 Original alignment 65.7 504.3 5.6e-20 Verteb Kappa light chain variable region (Fragment).
Q6PIH6 aa overlap(8-373:1-121)
coverage(51.48% : 50.42%) 240 Original alignment 65.6 594.1 5.6e-25 Hom IGKV1-5 protein.
A6NGI0 aa overlap(17-373:7-120)
coverage(50.21% : 95.00%) 120 Original alignment 65.5 575.4 6.1e-24 Hom Uncharacterized protein ENSP00000374816.
A6NK26 aa overlap(50-370:1-107)
coverage(45.15% : 99.07%) 108 Original alignment 65.4 506.9 4e-20 Hom Uncharacterized protein ENSP00000374799 (Fragment).
A2KBC1 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 522.8 5.3e-21 Hom Anti-(ED-B) scFV (Fragment).
A2KBC7 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 516.2 1.2e-20 Hom Anti-IFN-G scFv (Fragment).
A2KBC8 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 510.7 2.5e-20 Hom Anti-TeTox scFv (Fragment).
A2KBC4 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 510.7 2.5e-20 Hom Anti-TN-C scFv (Fragment).
A2KBC6 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 504.1 5.8e-20 Hom Anti-FactorVIII scFv (Fragment).
A2KBC3 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 503.0 6.7e-20 Hom Anti-(ED-B) scFV (Fragment).
A2KBC2 aa overlap(65-385:130-231)
coverage(45.15% : 42.86%) 238 Original alignment 65.4 501.9 7.7e-20 Hom Anti-(ED-B) scFV (Fragment).
A2JA19 aa overlap(68-385:1-100)
coverage(44.73% : 93.46%) 107 Original alignment 65.1 467.5 6.4e-18 Hom Anti-mucin1 light chain variable region (Fragment).
P01617 aa overlap(68-385:1-105)
coverage(44.73% : 92.92%) 113 Original alignment 65.1 488.0 4.6e-19 Hom Ig kappa chain V-II region TEW.
P01623 aa overlap(68-385:1-101)
coverage(44.73% : 92.66%) 109 Original alignment 65.1 501.4 8.2e-20 Hom Ig kappa chain V-III region WOL.
P01614 aa overlap(68-385:2-107)
coverage(44.73% : 92.17%) 115 Original alignment 65.1 491.1 3e-19 Hom Ig kappa chain V-II region Cum.
P01674 aa overlap(68-376:1-101)
coverage(43.46% : 93.52%) 108 Original alignment 65.0 489.4 3.8e-19 Verteb Ig kappa chain V-III region PC 2154.
Q53VP8 aa overlap(68-376:1-102)
coverage(43.46% : 91.07%) 112 Original alignment 65.0 471.6 3.8e-18 Verteb Kappa chain (Fragment).
P01597 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 65.0 475.1 2.4e-18 Hom Ig kappa chain V-I region DEE.
Q9UL86 aa overlap(68-367:1-95)
coverage(42.19% : 87.16%) 109 Original alignment 65.0 482.7 9e-19 Hom Myosin-reactive immunoglobulin kappa chain variable region (Fragment).
A2N2F4 aa overlap(77-367:1-92)
coverage(40.93% : 85.19%) 108 Original alignment 64.9 457.5 2.3e-17 Hom VK3 protein (Fragment).
A0N6R1 aa overlap(71-376:2-101)
coverage(43.04% : 90.91%) 110 Original alignment 64.7 462.9 1.1e-17 Verteb Rheumatoid factor RFA28 (Fragment).
Q811U6 aa overlap(71-376:1-100)
coverage(43.04% : 90.09%) 111 Original alignment 64.7 484.8 6.9e-19 Verteb Anti-human Fc gamma receptor III 3G8 kappa light chain variable region (Fragment).
Q9UL80 aa overlap(68-373:1-101)
coverage(43.04% : 88.60%) 114 Original alignment 64.7 490.1 3.5e-19 Hom Myosin-reactive immunoglobulin light chain variable region (Fragment).
A0N6R2 aa overlap(68-355:1-94)
coverage(40.51% : 86.24%) 109 Original alignment 64.6 455.3 3e-17 Verteb Rheumatoid factor RF1-7 (Fragment).
P01598 aa overlap(68-364:1-93)
coverage(41.77% : 86.11%) 108 Original alignment 64.6 469.6 4.8e-18 Hom Ig kappa chain V-I region EU.
A2NB46 aa overlap(68-370:1-96)
coverage(42.62% : 88.07%) 109 Original alignment 64.4 503.6 6.2e-20 Hom Cold agglutinin FS-2 L-chain (Fragment).
B1N7B8 aa overlap(68-385:1-100)
coverage(44.73% : 93.46%) 107 Original alignment 64.2 485.0 6.7e-19 Hom Cryocrystalglobulin CC1 kappa light chain variable region (Fragment).
P04206 aa overlap(68-385:1-101)
coverage(44.73% : 92.66%) 109 Original alignment 64.2 498.1 1.3e-19 Hom Ig kappa chain V-III region GOL (Rheumatoid factor).
P01600 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 64.2 493.7 2.2e-19 Hom Ig kappa chain V-I region Hau.
P04430 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 64.2 479.5 1.4e-18 Hom Ig kappa chain V-I region BAN.
P04431 aa overlap(8-367:3-116)
coverage(50.63% : 88.37%) 129 Original alignment 64.2 540.9 5.1e-22 Hom Ig kappa chain V-I region Walker precursor.
Q63ZX4 aa overlap(8-376:2-124)
coverage(51.90% : 51.04%) 241 Original alignment 64.2 556.7 6.8e-23 Verteb Igk-V8-16 protein (Fragment).
A2NVW8 aa overlap(68-376:1-102)
coverage(43.46% : 100.00%) 102 Original alignment 64.1 488.6 4.2e-19 Verteb Light chain variable region (Fragment).
P01631 aa overlap(68-376:1-102)
coverage(43.46% : 90.27%) 113 Original alignment 64.1 497.9 1.3e-19 Verteb Ig kappa chain V-II region 26-10.
A2IPI4 aa overlap(68-376:3-99)
coverage(43.46% : 85.84%) 113 Original alignment 64.1 474.8 2.5e-18 Hom HRV Fab 025-VL (Fragment).
A2NHM3 aa overlap(68-376:1-102)
coverage(43.46% : 46.58%) 219 Original alignment 64.1 487.0 5.1e-19 Verteb If kappa light chain (Fragment).
A6NED6 aa overlap(8-373:3-118)
coverage(51.48% : 98.31%) 118 Original alignment 63.9 559.1 5e-23 Hom Uncharacterized protein ENSP00000374793.
A0N8J1 aa overlap(56-370:1-99)
coverage(44.30% : 100.00%) 99 Original alignment 63.8 478.9 1.5e-18 Hom V(k)3 sequence of NG9 gene from fetal liver DNA precursor (Fragment).
A6NLC1 aa overlap(38-385:16-125)
coverage(48.95% : 83.33%) 132 Original alignment 63.8 513.3 1.8e-20 Hom Uncharacterized protein ENSP00000366632 (Fragment).
A6NJ98 aa overlap(38-385:16-125)
coverage(48.95% : 83.33%) 132 Original alignment 63.8 510.0 2.7e-20 Hom Uncharacterized protein ENSP00000366638 (Fragment).
A2MYE1 aa overlap(68-373:1-96)
coverage(43.04% : 100.00%) 96 Original alignment 63.7 474.7 2.5e-18 Hom A30 (Fragment).
A2NH53 aa overlap(62-382:2-101)
coverage(45.15% : 89.29%) 112 Original alignment 63.6 473.7 2.8e-18 Hom Immunogobulin kappa, VJ region (Fragment).
A6NC37 aa overlap(68-409:1-108)
coverage(48.10% : 100.00%) 108 Original alignment 63.2 492.6 2.5e-19 Hom Uncharacterized protein ENSP00000366640 (Fragment).
P01615 aa overlap(68-385:1-105)
coverage(44.73% : 92.92%) 113 Original alignment 63.2 488.0 4.6e-19 Hom Ig kappa chain V-II region FR.
A2IPI1 aa overlap(68-385:3-107)
coverage(44.73% : 88.98%) 118 Original alignment 63.2 491.0 3.1e-19 Hom HRV Fab N8-VL (Fragment).
A2IPI6 aa overlap(68-385:3-102)
coverage(44.73% : 88.50%) 113 Original alignment 63.2 482.5 9.2e-19 Hom HRV Fab 027-VL (Fragment).
Q6GMW0 aa overlap(8-358:1-111)
coverage(49.37% : 47.23%) 235 Original alignment 63.2 533.8 1.3e-21 Hom IGKV1-5 protein.
A2NJV5 aa overlap(8-373:1-121)
coverage(51.48% : 100.00%) 121 Original alignment 63.1 556.7 6.8e-23 Hom Kappa light chain variable region (Fragment).
A6NHD9 aa overlap(38-370:11-119)
coverage(46.84% : 91.60%) 119 Original alignment 63.1 510.7 2.5e-20 Hom Uncharacterized protein ENSP00000350041 (Fragment).
P80362 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 63.1 487.2 5.1e-19 Hom Ig kappa chain V-I region WAT.
Q65ZC0 aa overlap(68-376:1-102)
coverage(43.46% : 46.58%) 219 Original alignment 63.1 476.1 2.1e-18 Verteb Kappa light chain C_region (Fragment).
A2P1G9 aa overlap(68-376:1-102)
coverage(43.46% : 46.58%) 219 Original alignment 63.1 475.0 2.4e-18 Verteb Kappa light chain (Fragment).
P06310 aa overlap(8-355:1-115)
coverage(48.95% : 86.47%) 133 Original alignment 62.9 555.0 8.4e-23 Hom Ig kappa chain V-II region RPMI 6410 precursor.
A2NUE7 aa overlap(5-376:9-126)
coverage(52.32% : 77.63%) 152 Original alignment 62.9 590.4 9e-25 Verteb V(Kappa) gene product (Fragment).
Q9JL80 aa overlap(95-376:2-93)
coverage(39.66% : 89.32%) 103 Original alignment 62.8 441.3 1.8e-16 Verteb Anti-myosin immunoglobulin light chain variable region (Fragment).
A2MYE2 aa overlap(68-373:1-96)
coverage(43.04% : 100.00%) 96 Original alignment 62.7 470.3 4.4e-18 Hom A30 protein (Fragment).
A0N5G5 aa overlap(68-373:1-96)
coverage(43.04% : 81.36%) 118 Original alignment 62.7 472.3 3.4e-18 Hom Rheumatoid factor D5 light chain (Fragment).
A0N588 aa overlap(8-376:1-121)
coverage(51.90% : 92.37%) 131 Original alignment 62.6 569.4 1.3e-23 Verteb Anti-CD4 mAb M-T310 variable region light chain (Fragment).
Q66JS7 aa overlap(8-376:1-121)
coverage(51.90% : 50.84%) 238 Original alignment 62.6 555.7 7.7e-23 Verteb Igk protein.
A0A5E6 aa overlap(8-376:1-121)
coverage(51.90% : 50.84%) 238 Original alignment 62.6 555.7 7.7e-23 Verteb Igk-V21-4 protein.
A6NLY3 aa overlap(8-373:1-117)
coverage(51.48% : 100.00%) 117 Original alignment 62.3 560.2 4.3e-23 Hom Uncharacterized protein ENSP00000374805.
A6NEF8 aa overlap(8-373:3-118)
coverage(51.48% : 98.31%) 118 Original alignment 62.3 541.5 4.8e-22 Hom Uncharacterized protein ENSP00000374815.
A6ND45 aa overlap(8-373:3-118)
coverage(51.48% : 98.31%) 118 Original alignment 62.3 540.4 5.5e-22 Hom Uncharacterized protein ENSP00000374814.
P01607 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 62.3 485.0 6.7e-19 Hom Ig kappa chain V-I region Rei.
P01594 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 62.3 471.8 3.6e-18 Hom Ig kappa chain V-I region AU.
P01602 aa overlap(8-364:3-115)
coverage(50.21% : 96.58%) 117 Original alignment 62.2 529.5 2.2e-21 Hom Ig kappa chain V-I region HK102 precursor (Fragment).
P01685 aa overlap(68-361:2-93)
coverage(41.35% : 85.98%) 107 Original alignment 62.2 440.0 2.1e-16 Verteb Ig kappa chain V region 4135.
A2NVX1 aa overlap(68-376:1-102)
coverage(43.46% : 100.00%) 102 Original alignment 62.1 472.1 3.5e-18 Verteb Light chain variable region (Fragment).
A2NVX2 aa overlap(68-376:1-102)
coverage(43.46% : 100.00%) 102 Original alignment 62.1 463.4 1.1e-17 Verteb Light chain variable region (Fragment).
A6NHK9 aa overlap(23-370:6-120)
coverage(48.95% : 95.83%) 120 Original alignment 62.1 526.0 3.5e-21 Hom Uncharacterized protein ENSP00000315571 (Fragment).
P03977 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 62.1 484.8 6.9e-19 Verteb Ig kappa chain V-III region 50S10.1.
P01613 aa overlap(68-376:1-101)
coverage(43.46% : 90.18%) 112 Original alignment 62.1 474.8 2.5e-18 Hom Ig kappa chain V-I region Ni.
P01608 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 62.1 470.7 4.2e-18 Hom Ig kappa chain V-I region Roy.
P01611 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 62.1 464.1 9.8e-18 Hom Ig kappa chain V-I region Wes.
P01634 aa overlap(5-376:9-126)
coverage(52.32% : 86.76%) 136 Original alignment 62.1 534.0 1.2e-21 Verteb Ig kappa chain V-V region MOPC 21 precursor.
P01596 aa overlap(68-358:1-91)
coverage(40.93% : 85.05%) 107 Original alignment 61.9 459.8 1.7e-17 Hom Ig kappa chain V-I region CAR.
P01661 aa overlap(8-376:1-121)
coverage(51.90% : 92.37%) 131 Original alignment 61.8 545.2 3e-22 Verteb Ig kappa chain V-III region MOPC 63 precursor.
P01655 aa overlap(68-373:1-100)
coverage(43.04% : 89.29%) 112 Original alignment 61.8 484.7 6.9e-19 Verteb Ig kappa chain V-III region PC 7132.
A2IXM7 aa overlap(56-376:132-232)
coverage(45.15% : 41.56%) 243 Original alignment 61.7 479.8 1.3e-18 Verteb Anti-CD30 moab Ki-4 scFv (Fragment).
B0AZK4 aa overlap(56-376:159-259)
coverage(45.15% : 22.95%) 440 Original alignment 61.7 472.7 3.2e-18 Eukar BerH2-scFv-hpRNase precursor.
Q7TQM2 aa overlap(56-367:128-225)
coverage(43.88% : 40.33%) 243 Original alignment 61.5 462.2 1.2e-17 Verteb ScFv 6H8 protein (Fragment).
A6NN68 aa overlap(8-325:1-106)
coverage(44.73% : 100.00%) 106 Original alignment 61.3 482.9 8.8e-19 Hom Uncharacterized protein ENSP00000333154 (HCG1997566, isoform CRA_c).
P01619 aa overlap(68-385:1-101)
coverage(44.73% : 93.52%) 108 Original alignment 61.3 500.3 9.4e-20 Hom Ig kappa chain V-III region B6.
P01609 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 61.3 478.4 1.6e-18 Hom Ig kappa chain V-I region Scw.
P01610 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 61.3 461.9 1.3e-17 Hom Ig kappa chain V-I region WEA.
P01604 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 61.3 458.6 2e-17 Hom Ig kappa chain V-I region Kue.
A2NI60 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 61.3 465.2 8.5e-18 Hom BRE (Fragment).
Q58EU4 aa overlap(5-376:4-121)
coverage(52.32% : 49.58%) 238 Original alignment 61.3 573.3 8.1e-24 Verteb Igk-C protein.
Q6NTU5 aa overlap(38-370:16-125)
coverage(46.84% : 45.27%) 243 Original alignment 61.3 498.5 1.2e-19 Verteb Putative uncharacterized protein.
P04433 aa overlap(8-370:1-115)
coverage(51.05% : 100.00%) 115 Original alignment 61.2 535.1 1.1e-21 Hom Ig kappa chain V-III region VG precursor (Fragment).
A2NVX3 aa overlap(68-376:1-102)
coverage(43.46% : 100.00%) 102 Original alignment 61.2 467.8 6.1e-18 Verteb Light chain variable region (Fragment).
A2NVX0 aa overlap(68-376:1-102)
coverage(43.46% : 100.00%) 102 Original alignment 61.2 463.4 1.1e-17 Verteb Light chain variable region (Fragment).
P01656 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 61.2 478.2 1.6e-18 Verteb Ig kappa chain V-III region MOPC 70.
P01654 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 61.2 474.9 2.4e-18 Verteb Ig kappa chain V-III region PC 2880/PC 1229.
P01657 aa overlap(68-376:1-101)
coverage(43.46% : 90.99%) 111 Original alignment 61.2 466.1 7.5e-18 Verteb Ig kappa chain V-III region PC 2413.
Q8VIJ0 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 61.2 444.3 1.2e-16 Verteb Anti-DNA light chain (Fragment).
P18135 aa overlap(8-385:1-121)
coverage(53.16% : 93.80%) 129 Original alignment 61.1 568.4 1.5e-23 Hom Ig kappa chain V-III region HAH precursor.
P18136 aa overlap(8-385:1-121)
coverage(53.16% : 93.80%) 129 Original alignment 61.1 562.9 3.1e-23 Hom Ig kappa chain V-III region HIC precursor.
Q6PIH7 aa overlap(8-376:3-119)
coverage(51.90% : 49.58%) 236 Original alignment 61.0 538.2 7.3e-22 Hom IGKC protein.
A6NKP1 aa overlap(8-373:1-121)
coverage(51.48% : 100.00%) 121 Original alignment 60.7 556.7 6.8e-23 Hom Uncharacterized protein ENSP00000374801.
A2J423 aa overlap(56-376:129-229)
coverage(45.15% : 42.26%) 239 Original alignment 60.7 472.2 3.4e-18 Hom Anti-Mpl scFv (Fragment).
A2J422 aa overlap(56-376:134-234)
coverage(45.15% : 41.39%) 244 Original alignment 60.7 472.1 3.5e-18 Hom Anti-HER3 scFv (Fragment).
P01684 aa overlap(68-364:2-94)
coverage(41.77% : 85.32%) 109 Original alignment 60.6 443.2 1.4e-16 Verteb Ig kappa chain V region 3374.
P01599 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 60.4 450.9 5.3e-17 Hom Ig kappa chain V-I region Gal.
P01612 aa overlap(68-370:1-95)
coverage(42.62% : 87.16%) 109 Original alignment 60.4 452.0 4.6e-17 Hom Ig kappa chain V-I region Mev.
P04434 aa overlap(8-370:1-116)
coverage(51.05% : 100.00%) 116 Original alignment 60.3 529.5 2.2e-21 Hom Ig kappa chain V-III region VH precursor (Fragment).
A2NV19 aa overlap(29-376:7-121)
coverage(48.95% : 87.79%) 131 Original alignment 60.3 525.5 3.7e-21 Verteb Precursor polypeptide (AA -10 to 121) (413 is 1st base in codon) precursor (Fragment).
A0N6Y3 aa overlap(68-376:1-97)
coverage(43.46% : 90.65%) 107 Original alignment 60.2 447.7 8e-17 Verteb F30C7 light chain variable region (Fragment).
P01616 aa overlap(68-376:1-101)
coverage(43.46% : 90.18%) 112 Original alignment 60.2 468.3 5.7e-18 Hom Ig kappa chain V-II region MIL.
A2MY50 aa overlap(68-376:1-102)
coverage(43.46% : 89.47%) 114 Original alignment 60.2 452.8 4.2e-17 Verteb Anti-acid phosphatase variable light chain 18 (Anti-acid phosphatase variable light chain 11) (Fragment).
Q6GMX8 aa overlap(8-376:3-119)
coverage(51.90% : 49.58%) 236 Original alignment 60.2 525.0 4e-21 Hom IGKC protein.
A6NHX3 aa overlap(8-373:3-118)
coverage(51.48% : 98.31%) 118 Original alignment 59.8 519.5 8e-21 Hom Uncharacterized protein ENSP00000374797.
Q65ZC9 aa overlap(56-376:129-229)
coverage(45.15% : 42.08%) 240 Original alignment 59.8 456.8 2.5e-17 Hom Single-chain Fv (Fragment).
Q65ZC8 aa overlap(56-376:133-233)
coverage(45.15% : 41.39%) 244 Original alignment 59.8 467.7 6.2e-18 Hom Single-chain Fv (Fragment).
P01633 aa overlap(5-376:9-138)
coverage(52.32% : 87.25%) 149 Original alignment 59.6 555.4 8e-23 Verteb Ig kappa chain V-V region MPC11 precursor.
A6NN74 aa overlap(8-370:1-120)
coverage(51.05% : 100.00%) 120 Original alignment 59.5 531.5 1.7e-21 Hom Uncharacterized protein ENSP00000374804.
P01601 aa overlap(8-370:3-117)
coverage(51.05% : 98.29%) 117 Original alignment 59.5 493.2 2.3e-19 Hom Ig kappa chain V-I region HK101 precursor (Fragment).
P06311 aa overlap(8-385:1-120)
coverage(53.16% : 93.75%) 128 Original alignment 59.5 519.0 8.5e-21 Hom Ig kappa chain V-III region IARC/BL41 precursor.
A0N7H1 aa overlap(29-376:7-121)
coverage(48.95% : 82.14%) 140 Original alignment 59.5 517.4 1.1e-20 Verteb Tg10 kappa (Fragment).
A0A5D7 aa overlap(29-376:7-121)
coverage(48.95% : 48.32%) 238 Original alignment 59.5 505.2 5e-20 Verteb Igkv1-117 protein.
P01603 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 59.4 478.4 1.6e-18 Hom Ig kappa chain V-I region Ka.
P01593 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 59.4 456.4 2.6e-17 Hom Ig kappa chain V-I region AG.
P01595 aa overlap(68-385:1-100)
coverage(44.73% : 92.59%) 108 Original alignment 59.4 455.3 3e-17 Hom Ig kappa chain V-I region Bi.
Q569I7 aa overlap(8-376:3-119)
coverage(51.90% : 61.90%) 189 Original alignment 59.3 528.6 2.5e-21 Hom Putative uncharacterized protein.
Q7SZ36 aa overlap(8-376:1-121)
coverage(51.90% : 51.05%) 237 Original alignment 59.3 515.1 1.4e-20 Verteb MGC64265 protein.
Q6GMV9 aa overlap(8-376:1-118)
coverage(51.90% : 50.21%) 235 Original alignment 59.3 547.0 2.4e-22 Hom IGKC protein.
Q6PJF2 aa overlap(8-376:1-118)
coverage(51.90% : 50.21%) 235 Original alignment 59.3 540.4 5.5e-22 Hom IGK@ protein.
Q6GMX0 aa overlap(8-376:3-119)
coverage(51.90% : 49.58%) 236 Original alignment 59.3 519.5 8e-21 Hom Putative uncharacterized protein.
Q5XKG4 aa overlap(38-376:6-117)
coverage(47.68% : 47.86%) 234 Original alignment 59.3 482.2 9.5e-19 Verteb Igk-V28 protein (Fragment).
A0A5D8 aa overlap(38-376:11-117)
coverage(47.68% : 45.73%) 234 Original alignment 59.3 450.4 5.7e-17 Verteb LOC100046552 protein.
A0N6R0 aa overlap(68-376:1-97)
coverage(43.46% : 91.51%) 106 Original alignment 59.2 449.9 6e-17 Verteb Rheumatoid factor RF3-2C (Fragment).
A2NW56 aa overlap(68-376:1-97)
coverage(43.46% : 90.65%) 107 Original alignment 59.2 444.4 1.2e-16 Verteb E8 variable light chain (Fragment).
P01659 aa overlap(68-376:1-101)
coverage(43.46% : 90.18%) 112 Original alignment 59.2 480.3 1.2e-18 Verteb Ig kappa chain V-III region TEPC 124.
P01649 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 59.2 455.3 3e-17 Verteb Ig kappa chain V-V regions (Anti-arsonate antibodies).
P01646 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 59.2 439.9 2.2e-16 Verteb Ig kappa chain V-V region HP 123E6.
P84750 aa overlap(68-376:1-97)
coverage(43.46% : 80.17%) 121 Original alignment 59.2 439.2 2.4e-16 Verteb Ig kappa chain V region Mem5 (Fragment).
A6NJ14 aa overlap(8-373:1-116)
coverage(51.48% : 100.00%) 116 Original alignment 59.0 520.7 6.8e-21 Hom Uncharacterized protein ENSP00000374812.
Q6PIL8 aa overlap(8-373:1-117)
coverage(51.48% : 49.58%) 236 Original alignment 59.0 539.3 6.3e-22 Hom IGK@ protein.
A0N5G1 aa overlap(68-421:1-113)
coverage(49.79% : 97.41%) 116 Original alignment 58.8 486.7 5.4e-19 Hom Rheumatoid factor C6 light chain (Fragment).
A6NJV6 aa overlap(8-370:1-115)
coverage(51.05% : 100.00%) 115 Original alignment 58.7 501.0 8.6e-20 Hom Uncharacterized protein ENSP00000374806.
Q58EU8 aa overlap(8-376:1-122)
coverage(51.90% : 51.05%) 239 Original alignment 58.5 504.1 5.8e-20 Verteb Igk protein.
Q6GMX9 aa overlap(8-376:3-119)
coverage(51.90% : 49.58%) 236 Original alignment 58.5 480.0 1.3e-18 Hom IGKC protein.
P01643 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 58.3 443.2 1.4e-16 Verteb Ig kappa chain V-V region MOPC 173.
P01627 aa overlap(8-370:1-120)
coverage(51.05% : 100.00%) 120 Original alignment 57.9 505.2 5e-20 Verteb Ig kappa chain V-II region VKappa167 precursor.
Q05B55 aa overlap(8-385:1-125)
coverage(53.16% : 52.08%) 240 Original alignment 57.9 531.5 1.7e-21 Verteb IGK protein.
A0A5D9 aa overlap(8-376:1-122)
coverage(51.90% : 51.05%) 239 Original alignment 57.7 505.2 5e-20 Verteb Putative uncharacterized protein.
A6NND6 aa overlap(11-370:1-114)
coverage(50.63% : 100.00%) 114 Original alignment 57.5 483.5 8.1e-19 Hom Uncharacterized protein ENSP00000374791.
A6NIB6 aa overlap(8-373:3-118)
coverage(51.48% : 98.31%) 118 Original alignment 57.4 509.7 2.8e-20 Hom Uncharacterized protein ENSP00000374807.
P01635 aa overlap(8-370:1-115)
coverage(51.05% : 100.00%) 115 Original alignment 57.0 497.7 1.3e-19 Verteb Ig kappa chain V-V region K2 precursor (Fragment).
A0N7J6 aa overlap(8-373:1-116)
coverage(51.48% : 86.57%) 134 Original alignment 56.6 496.8 1.5e-19 Hom REV25-2 (Fragment).
B0JYP6 aa overlap(8-385:1-125)
coverage(53.16% : 52.08%) 240 Original alignment 56.3 509.5 2.9e-20 Verteb Putative uncharacterized protein.
Q4KM66 aa overlap(8-376:1-117)
coverage(51.90% : 50.00%) 234 Original alignment 56.1 472.4 3.4e-18 Verteb LOC500183 protein.
A1A540 aa overlap(56-382:6-108)
coverage(45.99% : 95.37%) 108 Original alignment 56.0 452.0 4.6e-17 Verteb Putative uncharacterized protein.
A0A5E3 aa overlap(8-376:1-120)
coverage(51.90% : 50.63%) 237 Original alignment 56.0 471.2 3.9e-18 Verteb LOC100046793 protein.
Q0VG91 aa overlap(38-382:10-118)
coverage(48.52% : 92.37%) 118 Original alignment 55.7 462.4 1.2e-17 Verteb LOC56304 protein (Fragment).
A9UM74 aa overlap(41-376:26-134)
coverage(47.26% : 80.74%) 135 Original alignment 55.4 445.1 1.1e-16 Verteb Putative uncharacterized protein (Fragment).
P01658 aa overlap(8-376:1-121)
coverage(51.90% : 91.67%) 132 Original alignment 55.3 530.9 1.9e-21 Verteb Ig kappa chain V-III region MOPC 321 precursor.
P01606 aa overlap(68-376:1-97)
coverage(43.46% : 89.81%) 108 Original alignment 55.3 458.6 2e-17 Hom Ig kappa chain V-I region OU.
A6NE59 aa overlap(14-373:3-120)
coverage(50.63% : 98.33%) 120 Original alignment 55.0 460.1 1.6e-17 Hom Uncharacterized protein ENSP00000366447 (Fragment).
Q811C3 aa overlap(17-370:4-118)
coverage(49.79% : 87.79%) 131 Original alignment 55.0 447.5 8.2e-17 Verteb Imunoglobulin gamma-3 kappa chain precursor (Fragment).
P04432 aa overlap(8-364:3-115)
coverage(50.21% : 87.60%) 129 Original alignment 54.6 471.7 3.7e-18 Hom Ig kappa chain V-I region Daudi precursor.
P01638 aa overlap(8-370:1-115)
coverage(51.05% : 100.00%) 115 Original alignment 54.5 473.6 2.9e-18 Verteb Ig kappa chain V-V region L6 precursor (Fragment).
P01637 aa overlap(8-376:1-117)
coverage(51.90% : 91.41%) 128 Original alignment 54.5 475.1 2.4e-18 Verteb Ig kappa chain V-V region T1 precursor.
Q5M838 aa overlap(8-376:1-117)
coverage(51.90% : 50.00%) 234 Original alignment 54.5 453.7 3.7e-17 Verteb LOC500180 protein.
Q7TS98 aa overlap(8-376:3-119)
coverage(51.90% : 49.58%) 236 Original alignment 54.5 471.2 3.9e-18 Verteb Anti-colorectal carcinoma light chain.
A6NFM8 aa overlap(8-373:1-121)
coverage(51.48% : 100.00%) 121 Original alignment 54.1 477.6 1.7e-18 Hom Uncharacterized protein ENSP00000374803.
P01641 aa overlap(8-370:3-117)
coverage(51.05% : 98.29%) 117 Original alignment 53.7 450.4 5.7e-17 Verteb Ig kappa chain V-V region MOPC 173B precursor.
A2IPW9 aa overlap(8-376:1-117)
coverage(51.90% : 92.13%) 127 Original alignment 53.7 448.8 7e-17 Verteb Immnogloblin light chain variable region precursor (Fragment).
Q52L95 aa overlap(8-376:3-119)
coverage(51.90% : 49.58%) 236 Original alignment 53.7 458.0 2.1e-17 Verteb Putative uncharacterized protein.
A0N586 aa overlap(8-376:1-117)
coverage(51.90% : 92.13%) 127 Original alignment 52.8 447.7 8e-17 Verteb Anti-CD4 mAb M-T151 variable region light chain (Fragment).
P01642 aa overlap(8-370:1-115)
coverage(51.05% : 100.00%) 115 Original alignment 52.1 457.1 2.4e-17 Verteb Ig kappa chain V-V region L7 precursor (Fragment).
Q8NEK0 aa overlap(8-527:1-175)
coverage(73.14% : 73.22%) 239 Original alignment 50.6 575.4 6.1e-24 Hom IGKV1-5 protein.
Number of sequences: 236